Akers BioSciences Regains Compliance with Nasdaq Listing Standards
11. Dezember 2019 09:30 ET
|
Akers Biosciences Inc.
Thorofare, New Jersey, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, announced today that on...
Akers Biosciences Announces Lifting of Temporary Suspension of Trading on the London Stock Exchange
26. Juli 2018 07:00 ET
|
Akers Biosciences Inc
THOROFARE, N.J., July 26, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Biosciences Announces Conference Call to Discuss Fiscal Year 2017 Earnings
15. März 2018 13:11 ET
|
Akers Biosciences Inc
THOROFARE, N.J, March 15, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will...